2.26
+0.01(+0.44%)
Currency In USD
| Previous Close | 2.26 |
| Open | 2.26 |
| Day High | 2.55 |
| Day Low | 2.07 |
| 52-Week High | 4.2 |
| 52-Week Low | 2.05 |
| Volume | 38,996 |
| Average Volume | 43,400 |
| Market Cap | 19.48M |
| PE | -0.94 |
| EPS | -2.4 |
| Moving Average 50 Days | 2.83 |
| Moving Average 200 Days | 3 |
| Change | 0.01 |
If you invested $1000 in Lisata Therapeutics, Inc. (LSTA) 10 years ago, it would be worth $3.86 as of March 12, 2025 at a share price of $2.26. Whereas If you bought $1000 worth of Lisata Therapeutics, Inc. (LSTA) shares 5 years ago, it would be worth $74.59 as of March 12, 2025 at a share price of $2.26.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lisata Therapeutics to Present at the Investival Showcase USA
GlobeNewswire Inc.
Mar 06, 2025 1:30 PM GMT
BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and oth
Lisata Therapeutics and GATC Health Consummate First Step in Strategic Collaboration to use AI to Derisk and Accelerate Drug Development
GlobeNewswire Inc.
Mar 05, 2025 1:30 PM GMT
Strategic collaboration harnesses GATC’s proprietary Artificial Intelligence-powered, validated Multiomics Advanced Technology™ platform to rapidly optimize and derisk drug discovery and development, thereby accelerating and economizing the tradition
Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025
GlobeNewswire Inc.
Feb 20, 2025 1:00 PM GMT
BASKING RIDGE, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and othe